Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2111-2116

  Crémieux, Anne Claude ^a   Mghir, Azzam Saleh ^a   Bleton, Rémy ^a   Manteau, Michel ^b   Belmatoug, Nadia ^a   Massias, Laurent ^a   Garry, Louis ^a   Sales, Nicole ^b   Mazière, Bernard ^b   Carbon, Claude ^a  

^a BICHAT HOSPITAL   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PEFLOXACIN; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTORADIOGRAPHY; BONE INFECTION; BONE TISSUE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GRAFT INFECTION; JOINT PROSTHESIS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9544250486     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2111     Document Type: Article

References (32)

1. Belmatoug, N., A. C. Crémieux, A. Volk, R. Bleton, A. Saleh-Mghir, M. Grossin, L. Garry, and C. Carbon. 1996. A new model of experimental prosthesis joint infection duc to methicillin-resistant Staphylococcus aureus: a microbiologie, histopathologic and magnetic resonance imaging characterization. J. Infect. Dis. 174:414-417.
2. Bouissou, H., D. Caujolle, F. Caujolle, and G. Milhaud. 1978. Tissu cartilagineux et acide nalidixique. C. R. Acad. Sci. Ser. D 286:1743-1746.
3. Costerton, J. W. 1984. The etiology and persistence of cryptic bacterial infections: a hypothesis. Rev. Infect. Dis. 6:S608-S616.
4. Crémieux, A. C., B. Mazière, J. M. Vallois, M. Ottaviani, A. Azancot, H. Raffoul, A. Bouvet, J. J. Pocidalo, and C. Carbon. 1989. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J. Infect. Dis. 159:938-944.
5. Crémieux, A. C., A. Saleh-Mghir, M. Manteau, N. Belmatoug, R. Bleton, L. Garry, N. Sales, B. Maziere, and C. Carbon. 1994. Autoradiographic pattern of distribution of sparfloxacin in an experimental prosthesis infection, abstr. A53, p. 19. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. 14C]-temafloxacin in cardiac vegetations. J. Antimicrob. Chemother. 36:2216-2221.
7. Crémieux, A. C., A. Saleh-Mghir, J. M. Vallois, B. Mazière, M. Ottaviani, J. J. Pocidalo, and C. Carbon. 1991. Pattern of diffusion of three quinolones throughout infected cardiac vegetations studied by autoradiography, abstr. 357, p. 158. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Dellamonica, P., H. Etesse-Carsenti, E. Bernard, V. Mondave, J. Durant, and C. Argenoon. 1990. Pefloxacin in the treatment of bone infections associated with foreign material. J. Antimicrob. Chemother. 26(Suppl. B):199-205.
9. Drancourt, M., A. Stein, J. N. Argenson, A. Zannier, G. Curval, and D. Raoult. 1993. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemolher. 37:1214-1218.
10. Drusano, G. L., D. E. Johanson, M. Rosen, and H. C. Standiford. 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicroh. Agents Chemother. 37:483-490.
11. Dworkin, R., G. Modin, S. Kuns, R. Rich, O. Zak, and M. Sande. 1990. Comparative efficacies of ciprofloxacin, pefloxacin and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis. Antimicroh. Agents Chemother. 34:1014-1016.
12. 18F-labeled fleroxacin in rabbits with E. coli infections studied with positron emission tomography. Antimicrob. Agents Chemother. 36:2286-2292.
13. 18F-fleroxacin in healthy human subjects studied by using positron emission tomography. Antimicrob. Agents Chemother. 37: 2144-2152.
14. Fitzgerald, R. H. 1989. Infection of hip prosthesis and artificial joints. Infect. Dis. Clin. N. Am. 3:329-338.
15. Gentry, L. O. 1991. Oral antimicrobial therapy for osteomyelitis. Ann. Intern. Med. 114:986-987.
16. Gentry, L. O., and G. R. Gomez. 1991. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob. Agents Chemother. 35:538-541.
17. Gentry, L. O., and G. G. Rodriguez. 1990. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicroh. Agents Chemother. 34:40-43.
18. Gillespsie, W. J. 1990. Infection in total joint replacement. Infect. Dis. Clin. N. Am. 4:465-484.
19. Henry, N. K., M. K. Roux, A. L. Whitesell, M. E. McConnel, and W. R. Wilson. 1987. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am. J. Med. 82(Suppl. 4A):73-75.
20. Ingham, B., D. W. Brentnall, E. A. Dale, and J. A. McFadzean. 1977. Athropathy induced by antibacterial fused N-alkyl-4-pyridone-3 carboxylic acids. Toxicol. Lett. 1:21-26.
21. Mader, J. T., and K. Adams. 1989. Comparative evaluation of daptomycin and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob. Agents Chemother. 33:689-692.
22. Mader, J. T., J. S. Cantrell, and J. Calhoun. 1990. Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. J. Bone Joint Surg. 72A:105-110.
23. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Norden, C. W. 1988. Lessons learned from animal models of osteomyelitis. J. Infect. Dis. 40:103-110.
25. Norden, C. W., J. D. Nelson, J. T. Mader, and G. B. Calandra. 1992. Evaluation of new anti-infection drugs for the treatment of infection of prosthetic hip joint. Clin. Infect. Dis. 15:S177-S181.
26. Osmon, D. R., J. M. Steckelberg, M. P. Wilhelm, M. R. Kealing, R. C. Walken, A. D. Hanssen, and W. R. Wibes. 1993. Medical management of total knee arthroplasty infection, p. 377-392. In J. A. Rand (ed.). Total knee arthroplasty. Raven Press, New York.
27. Satoh, T., M. Tanaka, F. Kikuchi, K. Inoshita, N. Sonoyama, H. Miyazaki, and Y. Matsnaga. 1991. Studies on the penetration of sparfloxacin into rabbit jaw bone. Eur. J. Clin. Microbiol. Infect. Dis. 1991(Special Issue):573-574.
28. Southwood, R. T., J. L. Rice, P. J. McDonald, P. H. Hakendorf, and M. A. Rozenbilds. 1985. Infection in experimental hip arthroplasties. J. Bone Joint Surg. 67A:1236-1244.
29. 35S-labelled benzyl penicillin in the body. Acta Radiol. 118(Suppl.):86-94.
30. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign-body infections. J. Infect. Dis. 162:96-102.
31. Widmer, A. F., A. Gaechler, P. E. Ochsner, and W. Zimmerli. 1992. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis. 14:1251-1253.
32. Zimmerli, W., R. Frei, A. F. Widmer, and Z. Rajacic. 1994. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J. Antimicrob. Chemother. 33:959-967.